title: Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.
abstract: X-linked mental retardation is a very common condition that affects approximately 1 in 600 males. Despite recent progress, in most cases the molecular defects underlying this disorder remain unknown. Recently, a study using the candidate gene approach demonstrated the presence of mutations in PAK3 (p21-activating kinase) associated with nonspecific mental retardation. PAK3 is a member of the larger family of PAK genes. PAK proteins have been implicated as critical downstream effectors that link Rho-GTPases to the actin cytoskeleton and to MAP kinase cascades, including the c-Jun amino-terminal kinase (JNK) and p38. We screened 12 MRX pedigrees that map to a large region overlying Xq21-q24. Mutation screening of the whole coding region of the PAK3 gene was performed by using a combination of denaturing gradient gel electrophoresis and direct sequencing. We have identified a novel missense mutation in exon 2 of PAK3 gene (R67C) in MRX47. This confirms the involvement of PAK3 in MRX following the report of a nonsense mutation recently reported in MRX30. In the MRX47 family, all affected males show moderate to severe mental retardation. No seizures, statural growth deficiency, or minor facial or other abnormal physical features were observed. This mutation R67C is located in a conserved polybasic domain (AA 66-68) of the protein that is predicted to play a major role in the GTPases binding and stimulation of Pak activity.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale U129-ICGM, Faculté de Médecine Cochin, Paris, France. bienvenu@cochin.inserm.fr
authors.forename: T
authors.initials: T
authors.lastname: Bienvenu
authors.forename: V
authors.initials: V
authors.lastname: des Portes
authors.forename: N
authors.initials: N
authors.lastname: McDonell
authors.forename: A
authors.initials: A
authors.lastname: Carrié
authors.forename: R
authors.initials: R
authors.lastname: Zemni
authors.forename: P
authors.initials: P
authors.lastname: Couvert
authors.forename: H H
authors.initials: HH
authors.lastname: Ropers
authors.forename: C
authors.initials: C
authors.lastname: Moraine
authors.forename: H
authors.initials: H
authors.lastname: van Bokhoven
authors.forename: J P
authors.initials: JP
authors.lastname: Fryns
authors.forename: K
authors.initials: K
authors.lastname: Allen
authors.forename: C A
authors.initials: CA
authors.lastname: Walsh
authors.forename: J
authors.initials: J
authors.lastname: Boué
authors.forename: A
authors.initials: A
authors.lastname: Kahn
authors.forename: J
authors.initials: J
authors.lastname: Chelly
authors.forename: C
authors.initials: C
authors.lastname: Beldjord
mesh_terms: D000595:Amino Acid Sequence; D004252:DNA Mutational Analysis; D008040:Genetic Linkage; D006801:Humans; D008607:Intellectual Disability / Q000235:genetics*; D008297:Male; D009154:Mutation; D010375:Pedigree; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D014960:X Chromosome; D054462:p21-Activated Kinases
chemical_list: D017346:Protein Serine-Threonine Kinases; D054462:p21-Activated Kinases